These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1020 related articles for article (PubMed ID: 24820457)
1. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457 [TBL] [Abstract][Full Text] [Related]
2. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381 [TBL] [Abstract][Full Text] [Related]
3. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353 [TBL] [Abstract][Full Text] [Related]
4. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of p16 Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245 [TBL] [Abstract][Full Text] [Related]
7. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma. Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737 [TBL] [Abstract][Full Text] [Related]
8. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias. Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203 [TBL] [Abstract][Full Text] [Related]
9. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467 [TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331 [TBL] [Abstract][Full Text] [Related]
11. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients. Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers of HPV in head and neck squamous cell carcinoma. Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304 [TBL] [Abstract][Full Text] [Related]
13. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
14. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression. Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma. Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907 [TBL] [Abstract][Full Text] [Related]
16. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
17. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Mehrad M; Carpenter DH; Chernock RD; Wang H; Ma XJ; Luo Y; Luo J; Lewis JS; El-Mofty SK Am J Surg Pathol; 2013 Sep; 37(9):1349-56. PubMed ID: 23797720 [TBL] [Abstract][Full Text] [Related]
18. HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers. Kanyilmaz G; Ekinci O; Muge A; Celik S; Ozturk F Asian Pac J Cancer Prev; 2015; 16(1):253-8. PubMed ID: 25640361 [TBL] [Abstract][Full Text] [Related]
19. The role of human papillomavirus in p16-positive oral cancers. Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035 [TBL] [Abstract][Full Text] [Related]
20. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore. Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]